Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(236)
Michael H. Davidson
17
Darbie L. Maccubbin
15
Harold E. Bays
14
Evan A. Stein
12
Leiv Ose
11
Journals
(23)
ATHEROSCLER SUPPL
12
Atherosclerosis
12
AMER J CARDIOL
6
J AMER COLL CARDIOL
5
AMER HEART J
4
Keywords
(90)
Embed
Subscribe
Academic
Authors
Yale B. Mitchel
Yale B. Mitchel,Cardiology,Endocrinology,Pharmacology
Edit
Yale B. Mitchel
Publications:
69
|
Citations:
686
Fields:
Cardiology
,
Endocrinology
,
Pharmacology
View FAQ about top research areas and Fields of study
Collaborated with
236 co-authors
from 1992 to 2012
|
Cited by
1708 authors
Cumulative
Annual
Sort by:
Publications
(69)
BibTeX
|
RIS
|
RefWorks
Download
Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction
D E Gutstein
,
R Krishna
,
D Johns
,
H K Surks
,
H M Dansky
,
S Shah
,
Y B Mitchel
,
J Arena
,
J A Wagner
Journal:
Clinical Pharmacology & Therapeutics - CLIN PHARMACOL THER
, vol. 91, no. 1, pp. 109-122, 2012
Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia
Hayes M. Dansky
,
Daniel Bloomfield
,
Patrice Gibbons
,
Sherry Liu
,
Christine McCrary Sisk
,
Diane Tribble
,
James M. McKenney
,
Thomas W. Littlejohn
,
Yale Mitchel
Journal:
American Heart Journal - AMER HEART J
, vol. 162, no. 4, pp. 708-716, 2011
Safety of extended-release niacin/laropiprant in patients with dyslipidemia
(
Citations: 2
)
James McKenney
,
Harold Bays
,
Michael Koren
,
John F. Paolini
,
Yale Mitchel
,
Abigaile Betteridge
,
Olga Kuznetsova
,
Aditi Sapre
,
Christine McCrary Sisk
,
Darbie Maccubbin
Journal:
Journal of Clinical Lipidology - J CLIN LIPIDOL
, vol. 4, no. 2, pp. 105-112.e1, 2010
Carotid atherosclerosis progression in familial hypercholesterolemia patients: A pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies
M. Vergeer
,
R. Zhou
,
M. L. Bots
,
R. Duivenvoorden
,
J. Koglin
,
F. Akdim
,
Y. B. Mitchel
,
R. Huijgen
,
A. Sapre
,
E. de Groot
,
E. J. G. Sijbrands
,
R. C. Pasternak
http://academic.research.microsoft.com/io.ashx?type=5&id=33731154&selfId1=6505455&selfId2=0&maxNumber=12&query=
Journal:
Circulation-cardiovascular Imaging - CIRC-CARDIOVASC IMAGING
, vol. 3, no. 4, pp. 398-404, 2010
Phase Z of the A to Z Trial Strategy in Patients With Acute Coronary Syndromes: Early Intensive vs a Delayed Conservative Simvastatin
Steven E. Nissen
,
Michael H. Davidson
,
William L. Isley
,
Yale B. Mitchel
,
Bruce Ovbiagele
,
John R. Crouse
Published in 2010.
Sort by:
Citations
(686 times by 524 publications)
Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction
D E Gutstein
,
R Krishna
,
D Johns
,
H K Surks
,
H M Dansky
,
S Shah
,
Y B Mitchel
,
J Arena
,
J A Wagner
Journal:
Clinical Pharmacology & Therapeutics - CLIN PHARMACOL THER
, vol. 91, no. 1, pp. 109-122, 2012
Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany
Galin V. MichailovGlenn
,
Glenn M. Davies
,
Karl J. Krobot
Journal:
European Journal of Health Economics - EUR J HEALTH ECON
, pp. 1-10, 2012
Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease
Michel Farnier
,
Kjetil Retterstøl
,
Armin Steinmetz
,
Albert Császár
Journal:
Diabetes & Vascular Disease Research - DIABETES VASC DIS RES
, vol. 9, no. 3, pp. 205-215, 2012
Effect of Atorvastatin Monotherapy and Low-Dose Atorvastatin/Ezetimibe Combination on Fasting and Postprandial Triglycerides in Combined Hyperlipedemia
Sang-Hak Lee
,
Seok-Min Kang
,
Yangsoo Jang
,
Namsik Chung
,
Donghoon Choi
Journal:
Journal of Cardiovascular Pharmacology and Therapeutics - J CARDIOVASC PHARMACOL THER
, vol. 17, no. 1, pp. 65-71, 2012
Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia A Prospective, Randomized, Double-Blind Trial
(
Citations: 76
)
Christie M. Ballantyne
,
John Houri
,
Alberto Notarbartolo
,
Lorenzo Melani
,
Leslie J. Lipka
,
Ramachandran Suresh
,
Steven Sun
,
Alexandre P. LeBeaut
,
Philip T. Sager
,
Enrico P. Veltri
Published in 2011.
Comments